These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26173356)

  • 1. Biochemical and Histopathological Investigation of Resveratrol, Gliclazide, and Losartan Protective Effects on Renal Damage in a Diabetic Rat Model.
    Ezel T; Kocyigit Y; Deveci E; Atamer Y; Sermet A; Uysal E; Aktaş A; Yavuz D
    Anal Quant Cytopathol Histpathol; 2015 Jun; 37(3):187-98. PubMed ID: 26173356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes.
    Yazgan ÜC; Taşdemir E; Bilgin HM; Deniz Obay B; Şermet A; Elbey B
    Arch Physiol Biochem; 2015; 121(4):157-61. PubMed ID: 26161595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of losartan in the nephropathy of the diabetic rat includes the control of monoamine oxidase type A activity.
    Manni ME; Bigagli E; Lodovici M; Zazzeri M; Raimondi L
    Pharmacol Res; 2012 Apr; 65(4):465-71. PubMed ID: 22123499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats.
    Palsamy P; Sivakumar S; Subramanian S
    Chem Biol Interact; 2010 Jul; 186(2):200-10. PubMed ID: 20307516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of glucose-regulated protein 78 and spliced X-box binding protein 1 in the protective effect of gliclazide in diabetic nephropathy.
    Zhang YW; Wang X; Ren X; Zhang M
    Diabetes Res Clin Pract; 2018 Dec; 146():41-47. PubMed ID: 28951332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys.
    Al-Hussaini H; Kilarkaje N
    Toxicol Appl Pharmacol; 2018 Jan; 339():97-109. PubMed ID: 29229234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.
    Komers R; Oyama TT; Beard DR; Tikellis C; Xu B; Lotspeich DF; Anderson S
    Kidney Int; 2011 Feb; 79(4):432-42. PubMed ID: 20962741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective effect of angiotensin II receptor blockage on rats with experimental diabetes nephropathy in early stage].
    Yang L; Fan J; Mi X; Liu X; Xu G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):317-9. PubMed ID: 12947726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the glycemic and lipidemic effect of monopril and losartan in normal and diabetic rats.
    el-Batran SA; el-Shenawy SM; Nofal SM; Abdel-Salam OM; Arbid MS
    Pharmacol Res; 2004 Aug; 50(2):131-6. PubMed ID: 15177300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
    Tawfik MK
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):600-9. PubMed ID: 22774400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats.
    Louro TM; Matafome PN; Nunes EC; da Cunha FX; Seiça RM
    Eur J Pharmacol; 2011 Feb; 653(1-3):89-94. PubMed ID: 21167150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of losartan on MT3-MMP and TIMP2 mRNA expressions in diabetic rat kidney].
    Wan X; Huang HH; Li JG
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1391-4. PubMed ID: 15604066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of losartan on expression of Janus kinase 2 and signal transducer and activator of transcription 3 in glomeruli of diabetic rats].
    Shi YH; Duan HJ; He N; Wang LH; Liu QJ; Gao F
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Nov; 17(11):662-6. PubMed ID: 16297319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
    Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
    Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats.
    Kamper M; Tsimpoukidi O; Chatzigeorgiou A; Lymberi M; Kamper EF
    Transl Res; 2010 Jul; 156(1):26-36. PubMed ID: 20621034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of integrin-linked kinase on renal tubular epithelial cell transdifferentiation in diabetic rats].
    Ning JP; Yang S; Ning C; Zeng YH; Liu LZ; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):104-8. PubMed ID: 17344597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of losartan on the levels of angiotensin II and its type-1 receptor in diabetic rat kidney].
    Wu W; Ding HL; Chen LH; Fu ZZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1742-4. PubMed ID: 17259110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Losartan downregulates the expression of transforming growth factor beta type I and type II receptors in kidney of diabetic rat].
    Guo ZX; Qiu MC
    Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):403-8. PubMed ID: 12895325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.